Clinical Trial Update: Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE) [Phase 2]

View source ↗

Summary

This Phase 2 interventional registry-embedded trial at MD Anderson tests whether open-label pravastatin or pentoxifylline/tocopherol can prevent lymphedema from…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrosis
• Lymphedema

Drugs mentioned

• Pravastatin (pravastatin)
• pentoxifylline/tocopherol (pentoxifylline and tocopherol)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphedema, Fibrosis | Phase 2 | Status: RECRUITING